C4 Therapeutics vs EnteroBiotix
C4 Therapeutics vs EnteroBiotix, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: C4 Therapeutics is on 49/100 and EnteroBiotix on 48/100.
Where each one leads
C4 Therapeutics
- domain rating: 41/100 against 29/100
- funding raised: $371M against $40.5M
EnteroBiotix
- agent readiness: 43/100 against 21/100
At a glance
| Measure | C4 Therapeutics | EnteroBiotix |
|---|---|---|
| What it is | Biopharmaceutical company developing novel cancer therapies using targeted protein degradation. | Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health. |
| Category | Biotech, Drug Discovery, Oncology, Clinical Trials | Biotechnology, Pharmaceuticals, Healthcare, Life Sciences |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Biotechnology |
| Founded | 2016 | 2017 |
| Headquarters | Boston, United States | Glasgow, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | C4 Therapeutics | EnteroBiotix |
|---|---|---|
| Total funding | $371M | $40.5M |
| Latest round | Series D | Funding Round |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | C4 Therapeutics | EnteroBiotix |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 49/100 | 48/100 |
| Traction | 40/100 | 38/100 |
| Team | 20/100 | 50/100 |
| Search visibility | 3/100 | 14/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (43/100) |
| Domain ratingLink authority, 0-100 | 41/100 | 29/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | C4 Therapeutics | EnteroBiotix |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CMS | WordPress | Squarespace |
| Analytics | Google Analytics 4, Google Tag Manager | Not detected |
C4 Therapeutics vs EnteroBiotix: common questions
Which is better, C4 Therapeutics or EnteroBiotix?
On our 0-100 score C4 Therapeutics rates higher (49/100 against 48/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do C4 Therapeutics and EnteroBiotix compare on the numbers?
C4 Therapeutics leads on domain rating (41/100 against 29/100), funding raised ($371M against $40.5M). EnteroBiotix leads on agent readiness (43/100 against 21/100).
Read the full C4 Therapeutics review and pricing or the EnteroBiotix review and pricing. You can also browse other C4 Therapeutics alternatives we track.